Ash Access Technology, Inc.

Ash Access Technology (Ash Access Technology) is a privately-held integrated specialty medical device company. The company is engaged in the development and marketing of proprietary technologies and devices for the treatment of diseases and disorders regarding the vascular access. The company develops advanced technology for the vascular access and infection control in both the acute and chronic health care environments. It is focused on the discovery and commercialization of a novel antimicrobial/antithrombotic therapy named Zuragen for the prevention and treatment of CRBSI and for the eradication of biofilm. The company has a portfolio of innovative products which concentrate on catheter related bloodstream infections (CRBSI) and poor patency (blood flow). It is headquartered in Indiana, the US.

Street: 
INOK Business Center
City: 
Lafayette
Postcode: 
47904
Federal State : 
United States
WebSite: 
www.ashaccess.com
Fax: 
1-765-7424823

Company Index Score

Current Index Score Historical Index Score
  • Ash Access Technology, Inc. currently scores 50 % in the index.
  • Ash Access Technology, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Ash Access Technology, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets